I. - Basic information

I.1 - Surname

Labudová

I.2 - Name

Martina

I.3 - Degrees

RNDr., PhD.

I.4 - Year of birth

1979

I.5 - Name of the workplace

Department of Microbiology and Virology, Faculty of Natural Sciences UC

I.6 - Address of the workplace

Mlynská dolina, Ilkovičova 6, 84215 Bratislava

I.7 - Position

assistant professor

I.8 - E-mail address

martina.labudova@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://projekty.portalvs.sk/?sid=xaYZVkuAIV7R6W38sW8minHjcUHZ5pr4dOMGdtvs

I.10 - Name of the study field in which a person works at the university

Biology

I.11 - ORCID iD

https://orcid.org/0000-0002-3197-9763

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.a - Name of the university or institution

Faculty of Natural Sciences CU

II.b - Year

2002

II.c - Study field and programme

Biology

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Natural Sciences CU

II.b - Year

2003

II.c - Study field and programme

Microbiology and Virology

II.3 - Third degree of higher education

II.a - Name of the university or institution

Faculty of Natural Sciences CU

II.b - Year

2009

II.c - Study field and programme

Microbiology and Virology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
independent researcher	Institute of Virology, BMC, SAS vvi	2009-present
assistant professor	Faculty of Natural Sciences CU	2022-present

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pathogenesis of viral diseases and medical virology	Biology	masters	Microbiology and Virology

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

V.4.c - Dissertation (third degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree	V.5.d - Field of study
Oncogenic viruses	Biology	masters	Microbiology and virology
Cell cultures	Biology	masters	Microbiology and virology
practical course from Virology	Erasmus Biology	first	Biology

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

430

VI.1.b - Over the last six years

140

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

430

VI.1.b - Over the last six years

155

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Tomaskova J., Labudova M., Kopacek J., Pastorekova S., Pastorek J. (2008). Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX. Virus Genes37(1):31-8; DOI: 10.1007/s11262-008-0240-2

Labudova M., Tomaskova J., Skultety L., Pastorek J., Pastorekova S. (2009). The nucleoprotein of lymphocytic choriomeningitis virus facilitates spread of persistent infection through stabilization of the keratin network. J. Virol. 83(16):7842-9; DOI: 10.1128/JVI.00309-09

Gibalová L., Sedlák J., Labudová M., Barančík M., Reháková A., Breier A., Sulová Z. (2009). Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein- mediated drug efflux activity. Gen. Physiol. Biophys. 28(4):391-403; DOI: 10.4149/pb_2009_04_391

Tomaskova J., Oveckova I., Labudova M., Lukacikova L., Laposova K., Kopacek J., Pastorekova S., Pastorek J. (2011). Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J. Virol. 85(24):13069-76; DOI: 10.1128/JVI.00829-11

Ditte Z., Ditte P., Labudova M., Simko V., Iuliano F., Zatovicova M., Csaderova L., Pastorekova S., Pastorek J. (2014). Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts. BMC Cancer 22(14):358; DOI: 10.1186/1471-2407-14-358

VI.3 - The most significant research/artistic/other outputs over the last six years

Supolikova M., Novakova E., Donatova K., Olejnikova P., Labudova M. (2023). Murine herpesvirus-68-related growth factors treatment correlates with decrease of p53 and HIF-1α protein levels. Pathog. Dis.17:81:ftad004; DOI: 10.1093/femspd/ftad004

Labudova M., Zduriencikova M., Fabianova A., Baratova M., Ditte P., Radvak P., Nemcovicova I., Pastorekova S., Pastorek J. (2019). Absence of keratin 1 restricts the course of infection with lymphocytic choriomeningitis virus strain MX. Acta Virol. 63(2):169-185; DOI: 10.4149/av_2019_209

Labudová M., Čiampor F., Pastoreková S., Pastorek J. (2018). Cell-to-cell transmission of lymphocytic choriomeningitis virus MX strain during persistent infection and its influence on cell migration. Acta Virol. 62(4): 424-434; DOI: 10.4149/av_2018_411

Fabianova A., Barathova M., Csaderova L., Simko V., Zatovicova M., Labudova M., Pastorek J. (2018). Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection. Oncotarget 9(16):12879-12893; DOI: 10.18632/oncotarget.24387

Simko V., Iuliano F., Sevcikova A., Labudova M., Barathova M., Radvak P., Pastorekova S., Pastorek J., Csaderova L. (2017). Hypoxia induces cancer-associated cAMP/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII. Sci. Rep.7(1):10121; DOI: 10.1038/s41598-017-09549-8

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion

Bamia, A; Marcato, V; Boissière, M; Mansuroglu, Z; Tamietti, C; Romani,M; Simon, D; Tian, G; Niedergang, F; Panthier, JJ; Flamand, M; Souès S; Bonnefoy, E, Jan 2021JOURNAL OF VIROLOGY 95 (1)

Bridging the Gap: Virus Long-Distance Spread via Tunneling Nanotubes

Jansens, RJJ; Tishchenko, A and Favoreel, HW; Apr 2020 JOURNAL OF VIROLOGY 94 (8)

Biocompatible carbon quantum dots for intelligent sensing in food safety applications: Opportunities and sustainability

Khan, A; Ezati, P; Kim JT; Rhim, JW

Mar 2023 MATERIALS TODAY SUSTAINABILITY 21

Biofilm inhibition by biocompatible poly(ε-caprolactone) nanocapsules loaded with essential oils and their cyto/genotoxicity to human keratinocyte cell line

Kapustová, M; Puskárová, A; Bucková, M; Granta, G; Napoli, E; Annusova, A; Mesarosova, M; Kozics, K; Pangallo, D; Geraci, C

Sep 5 2021 INTERNATIONAL JOURNAL OF PHARMACEUTICS 606

Boosting extracellular vesicle secretion

Debbi, L; Guo, SW; Safina, D; Levenberg, S

Oct 2022 BIOTECHNOLOGY ADVANCES 59

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

CEMEA Centrum pre využitie pokročilých materiálov SAV, ITMS: 313021T081, spoluriešiteľ

APVV-14-0120, Grafénová nanoplatforma na detekciu rakoviny. (2016-2019), riešiteľ

SAS-TUBITAk JRP 2013/02, SAS-TÜBITAK joint research cooperation, BioKer - Vývoj kompozitných keramických materiálov pre bioaplikácie. 2013-2016, riešiteľ

Leona Lauder and George Schwab Foundation, Úloha ektodomény CAIX v nádorovom raste a matastázovaní. (11/2014-12/2015), s preĺžením (12/2015-12/2016), riešiteľ

APVV 22-0565, Alginate-based microcapsules with enhanced stability and biocompatibility for encapsulation of pancreatic islets in diabetes treatment. (2022-2026), spoluriešiteľ

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2024-06-18

Name and surname:	RNDr. Martina Labudová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava